Immunome (IMNM) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to -$658.3 million.
- Immunome's Retained Earnings fell 5115.23% to -$658.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$658.3 million, marking a year-over-year decrease of 5115.23%. This contributed to the annual value of -$515.8 million for FY2024, which is 13148.73% down from last year.
- Immunome's Retained Earnings amounted to -$658.3 million in Q3 2025, which was down 5115.23% from -$600.8 million recorded in Q2 2025.
- Immunome's Retained Earnings' 5-year high stood at -$120.3 million during Q1 2023, with a 5-year trough of -$658.3 million in Q3 2025.
- In the last 3 years, Immunome's Retained Earnings had a median value of -$388.4 million in 2024 and averaged -$373.4 million.
- Per our database at Business Quant, Immunome's Retained Earnings tumbled by 23450.15% in 2024 and then plummeted by 5115.23% in 2025.
- Quarter analysis of 3 years shows Immunome's Retained Earnings stood at -$222.8 million in 2023, then crashed by 131.49% to -$515.8 million in 2024, then dropped by 27.63% to -$658.3 million in 2025.
- Its Retained Earnings stands at -$658.3 million for Q3 2025, versus -$600.8 million for Q2 2025 and -$557.4 million for Q1 2025.